The case for a different kind of assessment
A standard annual health check-up in India typically includes a complete blood count, basic metabolic panel, lipid panel (total cholesterol, LDL, HDL, triglycerides), liver enzymes, kidney function, and fasting glucose. This panel is designed to identify disease that is already present — anaemia, elevated LDL, impaired kidney function, overt diabetes.
The limitation of this approach is temporal. The pathological processes that lead to cardiovascular events, type 2 diabetes, and metabolic decline begin decades before they become diagnosable by standard screening. A man whose fasting glucose is 97 mg/dL (technically normal) may have had insulin resistance for 10 years. A woman whose LDL is 130 mg/dL (borderline) may have an ApoB of 145 mg/dL (substantially elevated) and a Lp(a) of 90 mg/dL (high risk). Neither the glucose nor the LDL tells the full story.
A longevity-focused biomarker panel is built around earlier signal detection — measuring the precursors of disease, not only the disease itself.
Category 1: Cardiometabolic markers
ApoB. The most informative lipid particle marker for atherosclerotic risk. Counts all atherogenic particles regardless of cholesterol content. Particularly predictive in Indian adults with the insulin-resistant phenotype. Order alongside LDL-C for the first evaluation; subsequent monitoring depends on results and treatment.
Lp(a). Genetically determined. Test once. If above 50 mg/dL, it is a permanent addition to the risk picture. Guides how aggressively other risk factors should be treated.
hs-CRP (high-sensitivity C-reactive protein). A marker of systemic inflammation. Elevated hs-CRP — even modestly, above 3 mg/L — independently predicts cardiovascular events, beyond traditional lipid markers. In the context of a longevity assessment, it indicates inflammatory burden that may not have a clinically apparent source.
Fasting insulin and HOMA-IR. As discussed in the metabolic panel article, this measures the degree of insulin resistance before fasting glucose becomes abnormal. In Indian adults, where insulin resistance often precedes overt metabolic disease by decades, this is the most actionable early signal in the cardiometabolic category.
HbA1c. A three-month average of blood glucose, providing more stable information than a fasting glucose. The prediabetes range (5.7–6.4%) is the intervention window — this is where dietary and lifestyle change has the greatest impact on trajectory.
Category 2: Hormonal markers
Thyroid panel (TSH, free T3, free T4, anti-TPO). Thyroid dysfunction is prevalent in India and has metabolic, cardiovascular, and cognitive consequences. A complete thyroid panel — not TSH alone — provides the full picture.
Total and free testosterone (men). Testosterone deficiency is common in Indian men with metabolic risk, and testosterone levels influence cardiovascular risk, metabolic function, and cognitive health. A morning sample with SHBG is required for accurate interpretation.
Oestrogen/progesterone (women, perimenopausal or postmenopausal). Hormonal status in women has significant cardiovascular implications: the estrogen-protective effect on the cardiovascular system decreases as oestrogen falls during perimenopause. A hormonal evaluation in this context is part of cardiometabolic risk assessment.
DHEAS. A weak androgen produced by the adrenal glands that serves as a reserve pool for sex steroid synthesis. DHEAS declines with age and is associated with various longevity parameters. Evaluating it in the context of a comprehensive hormonal assessment provides a more complete picture of adrenal function.
Category 3: Nutritional and inflammatory markers
Vitamin D (25-OH vitamin D). Vitamin D deficiency is near-universal in urban India, where sun exposure is limited by indoor lifestyles, pollution, clothing, and sunscreen use. Vitamin D insufficiency is associated with cardiovascular disease, immune dysfunction, insulin resistance, and cognitive decline. Below 30 ng/mL is insufficient; below 20 ng/mL is deficient.
Ferritin. Both low ferritin (iron deficiency, common in Indian women) and very high ferritin (a marker of inflammation or iron overload) are clinically relevant. Ferritin below 30 ng/mL is associated with fatigue and hair loss even without anaemia.
Homocysteine. Elevated homocysteine is an independent cardiovascular risk factor and is commonly elevated in Indian adults on low-protein or predominantly vegetarian diets. It is responsive to B-vitamin supplementation.
Uric acid. Elevated uric acid is a marker of metabolic stress and is independently associated with hypertension and cardiovascular risk.
Category 4: Organ function
Liver enzymes (ALT, GGT). Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in India and is closely linked to metabolic syndrome. Elevated ALT and GGT are early indicators.
Kidney function (eGFR, urine microalbumin-creatinine ratio). Microalbuminuria — the presence of small amounts of albumin in urine — is an early marker of renal microvascular damage and cardiovascular risk. It is detected by the urine albumin-creatinine ratio, which is not part of a standard blood panel.
Complete blood count with differential. Anaemia, inflammatory markers, and platelet abnormalities provide context for systemic health.
How to interpret the panel as a system
The value of a longevity biomarker panel is in the pattern — the metabolic narrative it tells — not in any individual result. A doctor reviewing this panel is asking:
- Where on the metabolic continuum is this patient — pre-disease, early-stage, established?
- What is the estimated cardiovascular risk over 10 years, and how does measured ApoB, Lp(a), and hs-CRP modify the standard risk score?
- What is the rate of change? (A single panel is a snapshot; repeated assessment every 12–24 months reveals trajectories.)
- Which findings are modifiable, and what interventions address them?
A panel without a doctor's interpretation is data. With interpretation, it becomes a clinical picture that guides specific, evidence-based action.